Nihar Desai, Allogeneic Bone Marrow Transplant Fellow at Princess Margaret Cancer Centre, shared a post on X about recent article he and his colleagues authored:
“Happy to share our new paper, out now in British Journal of Haematology.
GVHD free/relapse free survival (GRFS) is a clinically important endpoint in alloBMT, especially for young adults.
We used a CIBMTR dataset to analyse the impact of GvHD prophylaxis on GRFS in this population.”
Title: Impact of graft-versus-host disease prophylaxis strategies on GvHD-free/relapse-free survival in young adults undergoing unrelated donor allogeneic haematopoietic cell transplantation: A propensity score-matched analysis
Authors: Nihar Desai, Sergio Rodriguez Rodriguez, Eshrak Al-Shaibani, Tommy Alfaro Moya, Igor Novitzky-Basso, Arjun Datt Law
More posts featuring Nihar Desai on OncoDaily.